Carboplatin, Injection, 450 mg/45 mL (NDC 55150-335-01)
UNAVAILABLEEugia US LLC
Reason: Demand increase for the drug
On backorder. Recovery: TBD. Check wholesalers for inventory
Updated Aug 6, 2026
Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-34)
UNAVAILABLEAccord Healthcare Inc.
Reason: Requirements related to complying with good manufacturing practices
Estimated recovery: TBD; NDC is non-exempt
Updated Aug 5, 2026
Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-31)
UNAVAILABLEAccord Healthcare Inc.
Reason: Discontinuation of the manufacture of the drug
Discontinuation of the manufacture of the drug
Updated Aug 5, 2026
Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-12)
UNAVAILABLEAccord Healthcare Inc.
Reason: Requirements related to complying with good manufacturing practices
Estimated recovery: TBD; NDC is non-exempt
Updated Aug 5, 2026
Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-6)
UNAVAILABLETeyro Labs
Reason: Discontinuation of the manufacture of the drug
Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug
Updated Aug 4, 2026
Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-7)
UNAVAILABLETeyro Labs
Reason: Discontinuation of the manufacture of the drug
Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug
Updated Aug 4, 2026
Carboplatin, Injection, 10 mg/1 mL (NDC 63323-172-60)
UNAVAILABLEFresenius Kabi USA, LLC
Reason: Delay in shipping of the drug
Next release November 2026. Check wholesalers for inventory.
Updated Aug 4, 2026
Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-3)
UNAVAILABLETeyro Labs
Reason: Discontinuation of the manufacture of the drug
Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug
Updated Aug 4, 2026
Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-1)
UNAVAILABLETeyro Labs
Reason: Discontinuation of the manufacture of the drug
Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug
Updated Aug 4, 2026
Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-339-50)
UNAVAILABLEHospira, Inc., a Pfizer Company
Reason: Other
Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
Updated Jul 23, 2026
Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-262-05)
UNAVAILABLEHospira, Inc., a Pfizer Company
Reason: Other
Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay
Updated Jul 23, 2026
Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-339-18)
UNAVAILABLEHospira, Inc., a Pfizer Company
Reason: Demand increase for the drug
Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay
Updated Jul 23, 2026
Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-150-05)
UNAVAILABLEHospira, Inc., a Pfizer Company
Reason: Other
Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
Updated Jul 23, 2026
Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-600-05)
UNAVAILABLEHospira, Inc., a Pfizer Company
Reason: Other
Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
Updated Jul 23, 2026
Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-339-22)
UNAVAILABLEHospira, Inc., a Pfizer Company
Reason: Other
Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
Updated Jul 23, 2026
Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-360-18)
UNAVAILABLEHospira, Inc., a Pfizer Company
Reason: Other
Next Delivery: July 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay
Updated Jul 23, 2026
Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-339-56)
UNAVAILABLEHospira, Inc., a Pfizer Company
Reason: Other
Next Delivery: July 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay
Updated Jul 23, 2026
Carboplatin, Injection, 50mg/5mL (NDC 54288-164-01)
UNAVAILABLEGland Pharma Limited
Reason: Discontinuation of the manufacture of the drug
Discontinued; Distributed by BPI Labs, LLC
Updated Jul 22, 2026
Carboplatin, Injection, 600 mg/60 mL (NDC 55150-386-01)
UNAVAILABLEEugia US LLC
Reason: Demand increase for the drug
On backorder. Recovery: TBD. Check wholesalers for inventory
Updated Jul 20, 2026
Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-33)
UNAVAILABLEAccord Healthcare Inc.
Reason: Discontinuation of the manufacture of the drug
Discontinuation of the manufacture of the drug
Updated Jul 17, 2026
Carboplatin, Injection, 450mg/45mL (NDC 54288-166-01)
LIMITEDGland Pharma Limited
Reason: Demand increase for the drug
Estimated recovery: end of June 2026; Distributed by BPI Labs, LLC
Updated Jul 22, 2026
Carboplatin, Injection, 150mg/15mL (NDC 54288-165-01)
LIMITEDGland Pharma Limited
Reason: Demand increase for the drug
Estimated recovery: end of August 2026; Distributed by BPI Labs, LLC
Updated Jul 22, 2026
Carboplatin, Injection, 600 mg/65 mL (NDC 54288-167-01)
LIMITEDGland Pharma Limited
Reason: Demand increase for the drug
Distributed by BPI Labs, LLC
Updated Jul 22, 2026
Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4239-01)
LIMITEDTeva Pharmaceuticals USA, Inc.
Reason: Other
Estimated recovery: July 2027
Updated Jul 15, 2026
Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4246-01)
LIMITEDTeva Pharmaceuticals USA, Inc.
Reason: Other
Estimated recovery: September 2026
Updated Jul 15, 2026
Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4244-01)
LIMITEDTeva Pharmaceuticals USA, Inc.
Reason: Other
Estimated recovery: January 2027
Updated Jul 15, 2026
Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4248-01)
LIMITEDTeva Pharmaceuticals USA, Inc.
Reason: Other
Estimated recovery: May 2027
Updated Jul 15, 2026
Kyxata, Injection, 500 mg/50 mL (10 mg/mL) (NDC 83831-142-50)
AVAILABLEAvyxa Pharma, LLC
Updated Aug 4, 2026
Kyxata, Injection, 80 mg/8 mL (10 mg/mL) (NDC 83831-141-08)
AVAILABLEAvyxa Pharma, LLC
Updated Aug 4, 2026
FindRx is a medication availability service — we track which pharmacies have products in stock and route you to them. We are not a pharmacy, we don't sell or dispense medication, and nothing on this page is medical advice. Shortage details come from the FDA Drug Shortages list and manufacturer updates; local stock changes hour to hour, so confirm with the pharmacy at pickup. Questions about whether a medication is right for you belong with your prescriber or pharmacist.